Surgery – Diagnostic testing – Cardiovascular
Reexamination Certificate
2007-03-12
2009-11-24
Bockelman, Mark W (Department: 3766)
Surgery
Diagnostic testing
Cardiovascular
C600S513000, C600S516000
Reexamination Certificate
active
07623910
ABSTRACT:
A method differentiating LQT1 mutation from LQT2 mutation is disclosed. An ECG signal is obtained for a patient. At least a first ECG parameter and a second ECG parameter are determined from the ECG signal. A probability that the patient is an LQT1 carrier or an LQT2 carrier is determined based on a regression model which takes into account the first ECG parameter and the second ECG parameter. A system for assessing repolarization abnormalities is also disclosed. The system has a processor configured to differentiate between LQT1 and LQT2 based on at least two ECG parameters from ECG data. The system also has a data input coupled to the processor and configured to provide the processor with the ECG data. The system further has a user interface coupled to either the processor or the data input.
REFERENCES:
Matti Viitasalo, MD et al. “Ratio of Late to Early T-Wave Peak Amplitude in 24-h Electrocardiographic Recordings as Indicator of Symptom History in Patients With Long-QT Syndrome Types 1 and 2.” Journal of the American College of Cardiology, 47:112-120, doi:10.1016/j.jacc.2005.07.068 (Published online Dec. 13, 2005). Jul. 13, 2009.
J. K. Kanters, et al, T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome, Heart Rhythm (2004) 3, 285-292.
Yan, G.X., et al, “Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome,” Circulation, vol. 98, No. 18, pp. 1928-1936, Nov. 1998.
Zareba, W., et al,“Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group,”N.Engl.J.Med., vol. 339, No. 14.
Zareba, W., et al, “Location of mutation in the KCNQ1 and phenotypic presentation of long QT syndrome,” J.Cardiovasc.Electrophysiol., vol. 14, No. 11, pp. 1149-1153, Nov. 2003.
Couderc, J.P.,et al,“Identification of sotalol-induced changes in repolarization with T wave area-based repolarization duration parameters,”J.Electrocardiol., vol. 36, Suppl.
Vaglio,M., et al,“Fractionated repolarization velocity induced by sotalol in healthy subjects,” Computers in Cardiology 2005 32, 523-526 2005.
Priori, S.G., et al, “Evaluation of the spatial aspects of T-wave complexity in the long-QT syndrome,” Circulation, vol. 96,No. 9,pp. 3006-3012,Nov. 1997.
Zabel,M.,et al,“Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction,” Circulation,vo.12,No. 11,pp. 1252-1257,Sep. 2000.
Zabel,M.,et al,“Analysis of T-wave morphology from the 12-lead electrocardiogram for prediction of long-term prognosis in male US veterans,”Circulation,vol. 105,No. 9,pp. 1066-1070.
Press,W.H.,et al,“Numerical recipes in C: The Art of Scientific Computing,” Second ed., Cambridge University Press, 1992.
Kanters;J.K.,et al,“T wave morphology analysis distinguishes between KvLQT1 and HERG mutations in long QT syndrome,”Heart Rhythm,vol. 1,No. 3, pp. 285-292,Sep. 2004.
Struijk,J.J.,et al,“Classification of the long QT syndrome based on discriminant analysis of T-wave morphology,”Computers in Cardiology 2005 32, 511-514, 2005.
Kutner, M.H., et al, “Applied Linear Regression Models,” 4th ed. New York: McGraw-Hill/Irwin, 2004, pp. 582-585.
Badilini,F.,et al,“QT interval analysis on ambulatory electrocardiogram recordings: a selective beat averaging approach,”Med.Biol.Eng Comput., vol. 37, No. 1, pp. 71-79, Jan. 1999.
Lehmann,M.H.,et al,“Sexual dimorphism in the electrocardiographic dynamics of human ventricular repolarization: characterization in true time domain,”Circulation,vol. 104,No. 1.
Lehmann,M.H., et al,“T wave ‘humps’ as a potential electrocardiographic marker of the long QT syndrome,”J Am Coll Cardiol,vol. 24,No. 3,pp. 746-754,Sep. 1994.
Malfatto,G.,et al,“Quantitative analysis of T wave abnormalities and their prognostic implications in the idiopathic long QT syndrome,”J Am Coll Cardiol,vol. 23,No. 2,pp. 296-301.
Moss,A.J.,et al,“ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome,”Circulation,vol. 92,No. 10,pp. 2929-2934,Nov. 1995.
Schwartz,P.J., et al, “Diagnostic criteria for the long QT syndrome. An update,” Circulation, vol. 88, No. 2, pp. 782-784, Aug. 1993.
Couderc,J.P.,et al,“Drug-induced changes of ventricular repolarization: New incentives for quantifying T wave morphology,”Malmivuo,J. and Kauppinen,p. 5[1],167-70.2003.
Couderc,J.P.,et al,“T-wave morphology and arrhythmic events in patients with dilated cardiomyopathy,”Computers in Cardiology 2003 30, 149-152. 2003.
Priori,S.G.,et al,“Risk stratification in the long-QT syndrome,” N. Engl J Med May 8, 2003; 348(19): 1866-1874.
Zhang,L,et al,“Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome:ECG findings identify genotypes,”Circulation Dec. 5, 2000;102(23):2849.
Priori, S.G., et al, “Low Penetrance in the Long-QT Syndrome: Clinical Impact, ”Circulation Feb. 2, 1999;99(4):529-533.
Moss, A.J., et al,“Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome,” Circulation Feb. 15, 2000;101(6):616-623.
Schwartz, P.J., et al,“Left cardiac sympathetic denervation in the management of high-risk patients affected by the long-QT syndrome ,”Circulation Apr. 20, 2004;109(15):1826-1833.
Viskin,S.,“Cardiac pacing in the long QT syndrome: review of available data and practical recommendations,” J Cardiovasc Electrophysiol May 2000;11(5): 593-600.
Zareba, W., et al,“Implantable cardioverter defibrillator in high-risk long QT syndrome patients,”J Cardiovasc Electrophysiol Apr. 2003;14(4):337-341.
Napolitano, C.,et al,“Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice,”JAMA Dec. 21, 2005;294(23).
Priori, S.G., et al, “Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers,” JAMA Sep. 15, 2004;292(11):1341-1344.
Couderc, J.P., et al,“Repolarization morphology in adult LQT2 carriers with borderline prolonged QTc interval,” Heart Rhythm 2006.
Merri, M., et al, “Electrocardiographic quantitation of ventricular repolarization,” Circulation Nov. 1989; 80(5):1301-1308.
Padrini, R., et al, “Morphological algebraic models of the TU-wave patterns/in idiopathic long QT syndrome,” Int J Cardiol Feb. 2001;77(2-3):151-162.
Merri,M.,et al,“Relation between ventricular repolarization duration and cardiac cycle length during 24-hour Holter recordings. Findings in normal patients and patients . . . ”.
Benhorin, J., et al, “Long QT syndrome. New electrocardiographic characteristics,” Circulation Aug. 1990;82(2):521-527.
Benhorin, J., et al,“Evidence of genetic heterogeneity in the long QT syndrome,” Science Jun. 25, 1993;260(5116):1960-1962.
Zareba, W., et al, “TU wave area-derived measures of repolarization dispersion in the long QT syndrome,” J Electrocardiol 1998;30 Suppl:191-195.
Couderc, J.P., et al,“Electrocardiographic method for identifying drug-induced repolarization abnormalities associated with a reduction of the rapidly activating delayed . . . ”.
Badilini, F., et al, “Quantitative aspects of ventricular repolarization: relationship between three-dimensional T wave loop morphology and scalar QT dispersion,” Ann Noninvas.
Extramiana, F., et al,“Clinical assessment of drug-induced QT prolongation in association with heart rate changes,” Clin Pharmacol Ther Apr. 2005;77(4) 247-258.
Couderc Jean-Philippe
Vaglio Martino
Bockelman Mark W
Heslin Rothenberg Farley & & Mesiti P.C.
Miller Christopher B.
So Elizabeth K
University of Rochester
LandOfFree
ECG-based differentiation of LQT1 and LQT2 mutation does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with ECG-based differentiation of LQT1 and LQT2 mutation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and ECG-based differentiation of LQT1 and LQT2 mutation will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4078555